Inventor

CHEN KEVIN X

CN54 patents

⚠️ This page may combine multiple inventors who share the name “CHEN KEVIN X”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEN KEVIN X

SCHERING CORP

Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus

Inhibitors of hepatitis C virus NS3 protease

Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties

Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Ketoamides with cyclic P4&#39;S as inhibitors of NS3 protease of hepatitis C virus

Compounds as NS3-serine protease inhibitors of hepatitis C virus

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus

Inhibitors of hepatitis C virus NS3 protease

Ketoamides with cyclic P4&#39;s as inhibitors of NS3 serine protease of hepatitis C virus

Compounds as inhibitors of hepatitis C virus NS3 serine protease

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Compounds as inhibitors of hepatitis C virus NS3 serine protease

GENENTECH INC

Therapeutic compounds and uses thereof

Biheteroaryl compounds and uses thereof

Therapeutic compounds and uses thereof

Biheteroaryl compounds and uses thereof

GUANGDONG RAYNOVENT BIOTECH CO LTD

Crystal form and salt form of pyridoimidazole compound and preparation method therefor

Anti-influenza virus pyrimidine derivative

Anti-influenza virus pyrimidine derivative

Anti-influenza virus pyrimidine derivatives

MEDSHINE DISCOVERY INC

[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

DENDREON CORP

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Peptides as NS3-serine protease inhibitors of hepatitis C virus

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD

Azetidine derivative

Borate of azetidine derivative

Bicylic compound acting as an inhibitor

CHEN KEVIN X

4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections

Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C

PHAENO THERAPEUTICS CO LTD

Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof

Pyridone multiple-membered ring derivatives and use thereof

MERCK SHARP & DOHME

Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases

3-aminosulfonyl substituted indole derivatives and methods of use thereof

SAKSENA ANIL K

Peptides as NS3-serine protease inhibitors of hepatitis C virus

BENNETT FRANK

Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease

VERMA VISHAL A

5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases

ROSENBLUM STUART B

Fused tricyclic aryl compounds useful for the treatment of viral diseases

ZENG QINGBEI

Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C

CSTONE PHARMACEUTICALS SUZHOU CO LTD

Fused ring derivative as A2A receptor inhibitor

GUANGZHOU JOYO PHARMATECH CO LTD

Macrocyclic derivative and use thereof

CSTONE PHARMACEUTICAL SUZHOU CO LTD

Salt form and crystal form of A2A receptor antagonist and preparation method therefor

ANILKUMAR GOPINADHAN N

2,3-substituted indole derivatives for treating viral infections

LUOXIN PHARMACEUTICAL SHANGHAI CO LTD

Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus

Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus